Removal of germline encoded N-glycosylation sequons due to SHM was also observed in 18/430 cases (4.2%), again with a similar distribution among the 2 MM types [7/142 IgA cases (4.9%) versus 11/288 IgG cases (3.8%)]. This evidence concerns the gene CD79A and Miyoshi myopathy.